Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Gross Margin: 2021-2024

Historic Gross Margin for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to 50.14%.

  • Biofrontera's Gross Margin rose 2485.00% to 70.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.41%, marking a year-over-year decrease of 171.00%. This contributed to the annual value of 50.14% for FY2024, which is 134.00% up from last year.
  • According to the latest figures from FY2024, Biofrontera's Gross Margin is 50.14%, which was up 2.75% from 48.80% recorded in FY2023.
  • Biofrontera's Gross Margin's 5-year high stood at 97.84% during FY2021, with a 5-year trough of 37.57% in FY2022.
  • Over the past 3 years, Biofrontera's median Gross Margin value was 48.80% (recorded in 2023), while the average stood at 45.51%.
  • Per our database at Business Quant, Biofrontera's Gross Margin slumped by 6,027bps in 2022 and then skyrocketed by 1,123bps in 2023.
  • Biofrontera's Gross Margin (Yearly) stood at 97.84% in 2021, then slumped by 6,027bps to 37.57% in 2022, then soared by 1,123bps to 48.80% in 2023, then skyrocketed by 134bps to 50.14% in 2024.